Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Purification method for split influenza virus vaccine

A purification method and influenza virus technology, applied in the field of purification of influenza virus split vaccine, can solve the problems of large workload, cumbersome operation, poor homogeneity of samples in the same batch, etc. Effect

Active Publication Date: 2014-04-16
SINOVAC BIOTECH
View PDF4 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, most of the purification processes of domestically produced influenza vaccines use a combination of zonal rotor density gradient centrifugation and column chromatography for purification, or only density gradient centrifugation, or column chromatography; Density gradient centrifuges are limited by the single capacity. In large-scale production, it is usually necessary to use multiple centrifugation operations in batches. The operation is cumbersome, the workload is heavy, and it is easy to cause the problem of poor uniformity of the same batch of samples.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Purification method for split influenza virus vaccine
  • Purification method for split influenza virus vaccine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] The cultivation of embodiment 1 influenza virus

[0030] Include the following steps:

[0031] 1. Take 9-11 day-old chicken embryos, and remove unqualified chicken embryos such as damaged, dirty, dead, weak, and spermless embryos.

[0032] 2. Dilute the influenza virus working seeds to 2LgEID50, inoculate the allantoic cavity of chicken embryos, 0.2mL / embryo, and culture at 32°C for 48 hours.

[0033] 3. After the end of culture, select live embryos and chill them at 2°C for 12 hours.

[0034] 4. Harvest the allantoic fluid after the cold embryo is finished.

[0035] 5. Add formaldehyde solution with a final concentration of 1 / 4000 to inactivate for 96 hours.

[0036] 6. Obtain the influenza virus inactivation solution after inactivation.

Embodiment 2

[0037] The purification of embodiment 2 influenza virus split vaccines

[0038] Purify the influenza virus inactivated liquid harvested in Example 1, the purification process is as follows:

[0039] 1. The inactivation solution is concentrated 20 times by 300KD membrane bag ultrafiltration to obtain the ultrafiltrate.

[0040] 2. The ultrafiltrate was subjected to sucrose density gradient centrifugation in a KII continuous flow centrifuge with a sucrose concentration of 45% and a centrifugation time of 1 hour. The target sample was collected by a detector to obtain a superchaotrope.

[0041] 3. The ultra-chaotropic solution was filtered through a 100KD membrane bag using 0.01mol / L PBS buffer solution to remove sucrose and obtain a desugar solution.

[0042] 4. The desugar solution was subjected to molecular sieve chromatography with a loading volume of 2% of the column volume, and the gel used was Sehparose4Fast Flow. The eluent is 0.01mol / L PBS buffer, and the elution speed...

Embodiment 3

[0047] The purification of embodiment 3 influenza virus split vaccines

[0048] The influenza virus liquid harvested in Example 1 is purified, and the purification process is as follows:

[0049] 1. The virus harvest liquid obtained by chicken embryo culture in Example 1 was inactivated by formaldehyde, the final concentration of formaldehyde was 1 / 2000, and the inactivation time was 120 hours to obtain the influenza virus inactivation liquid.

[0050] 2. The inactivation solution is concentrated 40 times by 700KD membrane bag ultrafiltration to obtain ultrafiltrate.

[0051] 3. The ultrafiltrate was subjected to sucrose density gradient centrifugation in a KII continuous flow centrifuge with a sucrose concentration of 60% and a centrifugation time of 3 hours. The target sample was collected by a detector to obtain a superchaosate.

[0052] 4. The ultra-chaotropic solution was filtered through a 100KD membrane bag using 0.01mol / L PBS buffer solution to remove sucrose and obta...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a purification method for split influenza virus vaccine. An influenza virus strain is inoculated onto a chick embryo and cultured to obtain a virus solution; the virus solution is sequentially subjected to inactivation and ultrafiltration concentration to obtain an ultrafiltrate; the obtained ultrafiltrate is subjected to cane sugar density gradient centrifugation by using a KII continuous flow centrifuge to obtain an ultra centrifugal solution; the ultra centrifugal solution is subjected to ultrafiltration dialysis for cane sugar removal and molecular sieve gel chromatography to obtain a virus purification solution; the obtained virus purification solution is subjected to virus split by using a split agent TritonX-100 and sodium deoxycholate; after the split is over, the split agent is removed via ultrafiltration dialysis; impure protein is centrifugally removed from the obtained split solution; supernatant is collected, filtered and sterilized so as to obtain the purified influenza virus vaccine primary solution. The purification method is simple and convenient to operate, high in centrifugation capacity and suitable for large-scale production; by adopting a dual-split agent and a centrifugal process, the finished product is greatly improved in activity (hemagglutinin content / protein total content), and approaches the activity ratio of subunit vaccine, as a result, the high-grade split influenza virus vaccine product is obtained.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to a purification method of influenza virus split vaccine. Background technique [0002] The purification process of influenza virus split vaccine is to remove most of the impurity proteins and obtain influenza virus after the inactivated influenza virus harvest liquid is concentrated by ultrafiltration, continuous flow centrifugation, column chromatography, cracking, lysing agent removal, and centrifugation. The process of antigenic protein. [0003] At present, most of the purification processes of domestically produced influenza vaccines use a combination of zonal rotor density gradient centrifugation and column chromatography for purification, or only density gradient centrifugation, or column chromatography; Density gradient centrifuges are limited by the capacity of a single batch. In large-scale production, it is usually necessary to use multiple centrifugation operation...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/145A61P31/16
Inventor 王金辉郝中华陈栋胡伟李军尹卫东
Owner SINOVAC BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products